Table of Contents 2
List of Tables 3
List of Figures 3
Report Guidance 4
GlobalData Clinical Trials Report Coverage 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Restenosis to Cardiovascular Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Restenosis to Cardiovascular Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Restenosis Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 97
Abbreviations 97
Definitions 97
Research Methodology 98
Secondary Research 98
About GlobalData 99
Contact Us 99
Source 99

List of Tables
Restenosis Therapeutics, Global, Clinical Trials by Region, 2018* 6
Restenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Restenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Restenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 9
Restenosis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 10
Restenosis Therapeutics Clinical Trials, North America, Top Countries, 2018* 11
Restenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 12
Restenosis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 13
Proportion of Restenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 14
Restenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 15
Restenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 16
Proportion of Restenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 17
Restenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 18
Restenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 19
Restenosis Therapeutics, Global, Clinical Trials by Phase, 2018* 20
Restenosis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 21
Restenosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
Restenosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
Restenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24
Restenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 25
Restenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26
Restenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27
Restenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28

List of Figures
Restenosis Therapeutics, Global, Clinical Trials by Region (%), 2018* 6
Restenosis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 7
Restenosis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 8
Restenosis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 9
Restenosis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 10
Restenosis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 11
Restenosis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 12
Restenosis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 13
Proportion of Restenosis to Cardiovascular Clinical Trials, G7 Countries (%), 2018* 14
Restenosis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 15
Restenosis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 16
Proportion of Restenosis to Cardiovascular Clinical Trials, E7 Countries (%), 2018* 17
Restenosis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 18
Restenosis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 19
Restenosis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 20
Restenosis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 21
Restenosis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 22
Restenosis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 23
Restenosis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 24
Restenosis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 25
Restenosis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 26
Restenosis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 27
Restenosis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 28
GlobalData Methodology 98

Companies Mentioned
- Abbott Laboratories
- Sarepta Therapeutics Inc
- B. Braun Melsungen AG
- Boston Scientific Corp
- Medtronic Plc
- InnoRa GmbH
- Cardio Research Enschede BV
- Biotronik SE & Co KG
- Biosensors International Group Ltd
- Advanced Catheter Therapies Inc